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frequently used to investigate people's cognitions about illness in the context of the CS-SRM (for example, Pimm & Weinman, 1998; Neame & Hammond, 2005) . Horne and Weinman (2002) have further shown that, while people's perceptions about their illness influence illness-related behaviours such as whether they seek professional help, treatment beliefs are more proximal determinants of treatment-related behaviours such as adherence to medication regimens . Indeed, beliefs about treatments, such as 'the cure is worse than the disease', can impact on people's treatment behaviours (for example, opting for nonadherence to cope with side-effects; Johnson & Nielands, 2007; Perkins, 2002) . In a study of beliefs about non-pharmacological treatments, Yardley, Sharples, Beech and Lewith (2001) developed a dynamic model of treatment perceptions in which experiences of therapy modify perceptions of illness and of symptom change. Thus, within the framework of the CS-SRM it may be informative to investigate and elaborate the domain of treatment beliefs, in order to understand treatment-related behaviours.
Horne and colleagues (Horne, Weinman & Hankins, 1999) developed the Beliefs about Medicines Questionnaire (BMQ) to assess people's perceptions about medical treatments. For conditions where medication is just one of the treatment options it seems sensible also to assess beliefs about these other potential treatments, especially as they might relate to people's treatment choices. One choice that individuals make about their health care is whether to use complementary and alternative medicines rather than conventional medication approaches. Measures of beliefs about complementary and alternative medicines have been developed (Bishop, Yardley & Lewith, 2005; Finnigan, 1991; Hyland, Lewith & Westoby, 2003) , and have been used to inform people's treatment choices, but there appears to be no equivalent measure to assess beliefs about surgical procedures. In the current paper we report the development of a new measure relating to beliefs about surgical treatments (Beliefs about Surgery Questionnaire; BSQ). Together, these instruments measuring cognitive representations about medical and surgical treatments are validated against patients' treatment choices in the context of a clinical trial.
The BMQ was originally validated using a chronic illness sample (n = 524), including people diagnosed with asthma, diabetes, renal disease, psychiatric illness, and cardiac and general medicine inpatients. On the basis of Principal Components Analysis and Confirmatory Factor Analysis, four subscales were identified relating to beliefs about medications specific to the diagnosed condition ('Concerns' about taking the medication and 'Necessity' of taking the medication) and beliefs about medication in general ('Harmfulness' of medication in general and 'Overuse' of medication in general). The psychometric properties of these scales have been reported by Horne et al. (1999) and demonstrate high levels of discriminant validity, criterion-related validity and stability of the factor structure across the different illness groups.
Although beliefs about treatment have been investigated in relation to adherence to medication regimens and treatment preferences (Horne, 1999) , little research in this area has explored the issue of patient choice when surgery is one of the treatment options (Duric, Butow, Sharpe, Boyle, Beith, Wilcken, Heritier, Coates, Simes, & Stockler, 2007) . The addition of a measure of beliefs about surgery to the existing measure of beliefs about medication would provide the opportunity to explore such decisions. It is possible that people with less negative beliefs about surgery experience less anxiety associated with the surgery. As there is evidence that anxiety is associated with poorer clinical outcomes post-surgery (Johnston & Vogele, 1993) , this could be an important issue to explore.
The study was conducted in the context of a clinical trial, the REFLUX trial (Randomised Evaluation oF Laparoscopic sUrgery for refluX trial; Grant, Wileman, Ramsay, Bojke, Epstein, Sculpher, Kilonzo, Vale, Francis, Mowat, Krukowski, Campbell M, et al., 2008) , that evaluated these two treatment options in the case of gastro-oesophageal reflux disease (hereafter referred to as GORD). GORD is a relatively common condition with 10 to 20% of the "western" adult population experiencing symptoms weekly (Dent, El-Serag, Wallander, & Johansson, (2005) . The main symptoms are heartburn and acid regurgitation along with difficulty swallowing, chest pain, bloating and belching, all of which can have a significant impact on a person's quality of life. This reduction in quality of life has been reported to be associated with problems with eating and drinking, disturbed sleep, lack of vitality, body pain and poor emotional well being (Talley, Junghard, & Wiklund, 2001) . The majority of patients with GORD require long term medication for symptom relief, or surgery. However, it is still unclear which form of treatment is most effective. This REFLUX trial was a large multicentre randomised controlled trial, with parallel non-randomised preference groups, that aimed to compare the clinical and cost-effectiveness of relatively early laparoscopic surgery with continued medical management amongst people with GORD within the UK National Health Service.
Since the REFLUX trial involved non-randomised preference groups, it was felt important to include a measure that would investigate the process of patients' decisions about their treatment choice.
This population was of particular interest because GORD is a chronic condition for which there are two viable treatment options. Hence, in this context it was possible to test the proposition that treatment choice would be influenced not only by beliefs about medication but also by beliefs about surgery. However, these trial participants differed in two key ways from the samples in the BMQ validation study reported by Horne et al. (1999) . First, they had all been on long-term medication for GORD before being offered the option of surgery. Second, medication was primarily for symptom relief. Hence, it was instructive to investigate whether the BMQ was an appropriate measure for this patient group.
Thus, there were three aims of the study reported here: (1) to test the validity of the BMQ in the context of GORD (using baseline measures); (2) to develop a Beliefs about Surgery Questionnaire (BSQ) based where possible on items that paralleled the BMQ and to test the discriminant validity PAPER IN PRESS. PLEASE CHECK MANUSCRIPT STATUS WITH AUTHORS BEFORE CITING 8 of the BSQ (relative to the BMQ); (3) to test the criterion-related validity of the combined BMQ/BSQ.
The criterion against which to test the profile of combined scores was the treatment decision (medication or surgery) of participants who had the opportunity to choose their treatment (that is, those in the preference arms of the trial).
Methods

Interviews to elicit patients' views
During the development of a new GORD-specific measure of symptom severity (The Reflux questionnaire; Macran, Wileman, Barton & Russell, 2007) for use within the trial, a total of 31 people with GORD participated in one-to-one interviews (lasting approximately 30 minutes). Of these, 15 were receiving medical treatment and 16 had had surgery. Two focus group interviews (approximately 90 minutes) were also conducted, each involving 6 people, all of whom had previously undergone surgery. A semi-structured interview schedule was developed (for both the one-to-one and focus group interviews) to elicit views about the advantages and disadvantages of medical and surgical options, experience and impact of the illness, and views about service provision. The interviews were recorded, transcribed verbatim, anonymised and subjected to thematic analysis. The themes categorising patients' views suggested that patients focused on their past experience, that is, their experience of medication treatment of GORD. There was little discussion about the risks and benefits of the surgical treatment option. However, generic views about surgery did emerge in this analysis and these were used to generate items for the BSQ, following the framework of generic beliefs about medicines outlined in the BMQ.
Item development
Item content for the Beliefs about Surgery Questionnaire (BSQ) was informed by three sources: the BMQ; the literature on informed decision making about treatment options (Bekker et al., 1999;  HTA review); and thematic analysis of the data elicited from patients in the interviews about GORD symptoms. Table 1 presents 12 items generated from the three sources. Following discussion among the research team, four of these items were discarded, either because they duplicated the content of other items or because the wording was potentially problematic. The resulting 8-item questionnaire (with a response format replicating that of the BMQ: 1 -Strongly disagree -to 5 -Strongly agree) was included with the 18-item BMQ in the trial measures at baseline. A total of 357 were recruited to the randomised arm of the trial and 453 to the preference study.
The participants in the randomised arm of the trial were, on average, 46 years old (SD=11.1) and 66% were men. In the preference arm, the participants tended to be older (mean = 50 years, SD=11.8) and there were slightly fewer men (61%).
Patients who consented to take part in the trial, both randomised and preference groups, were asked to complete a baseline postal questionnaire which they returned in a pre-paid envelope to the trial office for analysis. The questionnaire contained the Reflux questionnaire (Macran et al., 2007) , the EQ-5D (EuroQol Group, 1990 ) the SF36 (Jenkinson, Layte, Wright & Coulter, 1996) , the BMQ and the BSQ.
Analytic strategy
Three analyses were conducted, each addressing one of the study aims. First, rather than structural equation modelling, the same analytic procedures were used as reported by Horne et al. (1999) . That is, an exploratory Principal Components Analysis was conducted on the BMQ items and Confirmatory Factor Analysis was performed by computing Pearson's correlations for factor loadings against: (a) the theoretical model of predicted factor loadings and (b) the empirical model of factor loadings reported by Horne et al. As described by Horne et al., the theoretical model was defined by assigning a factor loading of '1' to all items expected to load on the factor and all other items were assigned a loading of '0'. This strategy permitted comparisons of two expected patterns of factor loadings (the theoretical 0-1 loadings and the empirically derived loadings from Horne et al.) with the pattern derived from the REFLUX sample. This was done to achieve a clear replication of the original validation study.
Second, the discriminant validity of the BSQ relative to the BMQ was assessed by a further exploratory Principal Components Analysis on the combined items from the BMQ and BSQ, using a non-orthogonal (Direct Oblimin) method of rotation. The factor scree plot and eigenvalues were used to select the number of factors. An exploratory rather than confirmatory approach was used, as four of the eight items were different from BMQ items and so there were few grounds on which to make assumptions or predictions about the underlying factor structure of the BSQ.
Third, Discriminant Function Analysis was used to test the criterion-related validity of the combined BMQ/BSQ. This form of validity would be demonstrated if the profile of scores enabled correct classification of cases to the Surgery and Medication groups in the preference groups but not in the randomised groups.
Results
A total of 794 REFLUX trial participants completed and returned baseline questionnaires. Of these, both the BMQ and BSQ were completed by 414 (93%) in the preference arm and 325 (93%) in the randomised arm of the trial. Thus, 739 cases were analysed. These were complete cases and thus there were no missing data. 
Exploratory Principal Components Analysis on BMQ items
Based on the structure of the instrument reported by Horne et al. (1999) , the BMQ was expected to comprise 4 factors (corresponding to the two subscales for each of the item pools relating to beliefs about Medication in General Medicine and Medicines for a specific condition). Using an eigenvalue cut-off of 1.1 (Jolliffe, 1986) , the REFLUX data yielded four factors that together accounted for 53.3% of the variance in the scores. Using a cut-off of 0.3 for item inclusion (Tabachnik & Fidell, 1996) , every item in the item pool loaded on to a factor (and 17 of the 18 items loaded at >0.4).
Two of the 18 items had diffuse loading. Factor 1 of the REFLUX data corresponded to the General Harm scale and part of the General Overuse scale of Horne et al. (1999) and was labelled 'General: uncertain risk/efficacy balance'. Factors 2 and 3 corresponded exactly to Horne's Specific Concerns and Specific Necessity factors so the same labels were retained. Factor 4 corresponded mostly to Horne's General Overuse scale and was labelled 'General: unintended effects'.
Confirmatory factor analysis on BMQ items
To test the consistency between the factor solution derived from the REFLUX sample and that of the chronic illness groups reported by Horne et al. (1999) , a Confirmatory Factor Analysis was conducted by computing the correlations between all the factor loadings derived from the REFLUX data set and (a) a theoretical model, defined by assigning factor loadings of '1' to items expected to load on a factor, or else '0'; and (b) Horne et al.'s empirically derived factor loadings. Results of the Confirmatory Factor Analysis are presented in Table 2 .
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Exploratory Principal Components Analysis on BMQ/BSQ items
A Principal Components Analysis (with Oblimin rotation) was conducted on all BMQ and BSQ items together. The scree plot and eigenvalues suggested that it was appropriate to extract six factors, which together accounted for 54.5% of the variance in the scores. Using a cut-off of 0.3 for item inclusion, all items in the item pool loaded on to a factor and five of the 26 items had diffuse loading. Table 3 presents the item loadings.
In the solution for the combined BMQ/BSQ, beliefs about surgery appeared to be clearly discriminable from beliefs about medicines, as there was only one diffuse item loading on to a Medication factor and a Surgery factor and all between-factor correlations were less than 0.3 (Table   4) . 
Discriminant function analysis
The next question concerned the capacity of the BMQ/BSQ scores to discriminate between participants who chose to undergo surgery and those who chose to remain on medication. Six composite belief scores were computed (mean scores) for each participant, corresponding to the six factors in the combined BMQ / BSQ factor solution ( Table 4 ). The six variables were entered as independent variables in a discriminant function analysis on data from the preference groups. This profile of scores resulted in correct classification of 78.5% of the cases into Surgery or Medication groups. This was significantly greater than chance, χ 2 (6) = 205.9, p < .001. Using Wilks' Lambda to test for equality of group means, and a significance criterion of 0.01 to adjust for multiple tests, three out of the six variables significantly contributed to the solution: Medication -Specific Concerns, Surgery -Overuse/Harm, and Surgery -Concerns (all ps < .001). In contrast, discriminant function analysis on data from the randomised groups resulted in correct classification of 54.5% of the cases into Surgery or Medication groups. This was not significantly greater than chance, χ 2 (6) = 9.4, p = .154. Table 5 presents classification results for (a) the preference groups and (b) the randomised groups.
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Finally, means, standard deviations and internal consistency co-efficients of the six scales are presented in Table 6 .
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Discussion
The CS-SRM (Leventhal, et al. 1998) First, this study provided support for the validity of the BMQ for individuals suffering from GORD. In particular, the loadings on items measuring Specific Necessity and Specific Concerns about medication mapped almost perfectly across the two studies. The difference in the factor structure across the items measuring beliefs about medication in general may be due, in part, to the nature of GORD and the demographic profile of this sample. In contrast to the illness groups investigated by Horne and colleagues, GORD is not perceived as life threatening, although it has serious implications for quality of life. Furthermore, it is likely that the samples in the Horne study had a larger number of co-morbidities and this may have influenced the pattern of scores for beliefs about medication in general. In the light of these differences it is even more striking that the Medication Specific scales corresponded so closely in the two studies.
Second, when participants were asked to answer questions relating to beliefs about surgery, their answers yielded factors that were discriminable from those relating to beliefs about medications.
This suggests that these participants held distinctive patterns of beliefs about these two kinds of treatment, rather than about health-care interventions in general. Scores for Concerns about surgery showed the greatest mean difference between the participants who chose surgery and those who chose to continue their medication.
Third, data from the BMQ and the BSQ provided evidence of criterion-related validity of the BMQ and the BSQ, in that the profile of scores on the BMQ and BSQ distinguished between the surgery group and the medication group in the preference arms of the trial but not in the randomised arms.
In the literature there is some overlap between types of validity and some may prefer to refer to this as concurrent validity or predictive validity (Streiner & Norman, 2003) . The term 'criterion-related' validity has been used here because it more clearly specifies the method used to test whether the items measured the intended constructs.
Limitations to these findings should be noted and there is more work to be done to establish the generalisability of the BSQ. In particular, we did not assess its validity in samples with other illnesses or outside a trial context. Nor did we assess test-retest reliability or sensitivity to change.
The low internal consistency of the Surgery Concerns subscale should also be noted. In particular, the properties of one item, whose wording was different from the others, was problematic. This was the item I would be willing to have an uncomfortable test to assess my suitability for surgery. Both skewness and kurtosis were greater than 1 and it loaded (negatively) on to both the Surgery subscales. Despite these drawbacks, we chose to include this item in the final questionnaire, as it emerged strongly as a theme in the interview study and thus is likely to contribute to the content validity of the measure.
The combined BMQ and BSQ may be useful tools in clinical practice as well as in research.
Knowing the scores on these two questionnaires could help clinicians to counsel patients who have high levels of concern, or to help patients make better decisions about their treatment. In particular, the items could be used as stimulus materials for a value elicitation / clarification technique, as a decision aid for patients. It could be helpful to explore these possibilities in future research. Table 2 . Confirmatory factor analysis for the BMQ scales, testing factor loadings (on three factors) from the REFLUX data set against (a) the theoretical and (b) the empiricallyderived model. 
